Top 10 Dividend Stocks To Invest In 2019

NOVOZYMES A/S/S (NASDAQ: EIGR) and Eiger Biopharmaceuticals (NASDAQ:EIGR) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk.

Earnings & Valuation

Get NOVOZYMES A/S/S alerts:

This table compares NOVOZYMES A/S/S and Eiger Biopharmaceuticals’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NOVOZYMES A/S/S $2.21 billion 6.04 $473.62 million $1.59 34.43
Eiger Biopharmaceuticals N/A N/A -$42.44 million ($4.86) -2.65

NOVOZYMES A/S/S has higher revenue and earnings than Eiger Biopharmaceuticals. Eiger Biopharmaceuticals is trading at a lower price-to-earnings ratio than NOVOZYMES A/S/S, indicating that it is currently the more affordable of the two stocks.

Top 10 Dividend Stocks To Invest In 2019: CRB Futures Index(CR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Crane (CR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    DA Davidson set a $111.00 price target on Crane (NYSE:CR) in a research report released on Friday. The brokerage currently has a buy rating on the conglomerate’s stock.

  • [By Joseph Griffin]

    Shares of Crew Energy (TSE:CR) have been given a consensus recommendation of “Buy” by the eleven research firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is C$3.37.

  • [By Shane Hupp]

    BlackRock Inc. grew its stake in Crane Co. (NYSE:CR) by 2.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,303,084 shares of the conglomerate’s stock after acquiring an additional 93,264 shares during the period. BlackRock Inc. owned 7.21% of Crane worth $399,069,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Crane (CR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Crew Energy (TSE:CR) had its price objective lowered by equities research analysts at Canaccord Genuity from C$4.50 to C$4.00 in a report issued on Tuesday. Canaccord Genuity’s price objective indicates a potential upside of 101.01% from the stock’s previous close.

Top 10 Dividend Stocks To Invest In 2019: P.T. Telekomunikasi Indonesia Tbk.(TLK)

Advisors’ Opinion:

  • [By Anders Bylund]

    Telekomunikasi Indonesia (NYSE:TLK), the largest telecommunications company in Indonesia, reported first-quarter results on Tuesday, May 2. Top-line sales rose modestly in the first quarter thanks to higher wireless subscriber counts and a healthy broadband business, but those upsides had to overcome a substantial headwind from a mass exodus of old-school wireline subscribers.

  • [By Max Byerly]

    Telekomnks Indn Prsr Tbk Prshn Prsrn (NYSE:TLK) was upgraded by equities research analysts at Macquarie from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports.

  • [By Lisa Levin]

    Tuesday afternoon, the telecommunication services shares climbed 1.18 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 7 percent, and Telekomnks Indn Prsr Tbk Prshn Prsrn-ADR (NYSE: TLK), up 3 percent.

Top 10 Dividend Stocks To Invest In 2019: Pinnacle West Capital Corporation(PNW)

Advisors’ Opinion:

  • [By Shane Hupp]

    Profund Advisors LLC lowered its stake in Pinnacle West Capital Co. (NYSE:PNW) by 26.6% during the first quarter, Holdings Channel reports. The fund owned 7,249 shares of the utilities provider’s stock after selling 2,622 shares during the period. Profund Advisors LLC’s holdings in Pinnacle West Capital were worth $578,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Pinnacle West Capital (NYSE:PNW) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “In last three months, shares of Pinnacle West Capital Corporation have outperformed than its industry. Pinnacle West Capital is well positioned to gain from the ongoing economic improvement in its service territories and customer growth. Pinnacle West Capital’s long-term capital expenditure plan will further strengthen its traditional generation, transmission and distribution capabilities. The company is also investing in battery storage projects, which will make its renewable projects more effective. The company continues to have a strong credit rating. However, Pinnacle West Capital is subject to comprehensive regulations by federal, state and local regulatory agencies. In addition, its operations are subject to fluctuations in the commodity price and weather, as well as operational hazards.”

  • [By Joseph Griffin]

    Pinnacle West Capital (NYSE:PNW) last posted its quarterly earnings results on Friday, August 3rd. The utilities provider reported $1.48 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.44 by $0.04. The firm had revenue of $974.12 million during the quarter, compared to analysts’ expectations of $939.59 million. Pinnacle West Capital had a return on equity of 9.12% and a net margin of 12.95%. The company’s revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.49 earnings per share. analysts anticipate that Pinnacle West Capital Co. will post 4.45 earnings per share for the current year.

  • [By Jon C. Ogg]

    Pinnacle West Capital Corp. (NYSE: PNW) was raised to Outperform from Neutral and the price target was raised to $87 from $85 at Credit Suisse.

    Salesforce.com Inc. (NYSE: CRM) was reiterated as Outperform and the price target was raised to $140 from $125 at JMP Securities.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Pinnacle West Capital (PNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Dividend Stocks To Invest In 2019: PPL Corporation(PPL)

Advisors’ Opinion:

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) dropped about 1.7% Tuesday to post a new 52-week low of $30.44 after closing at $30.95 on Friday. Volume was around 4.1 million about 10% below the daily average of around 4.6 million. The company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $30.74 after closing Tuesday at $30.76. The 52-week high is $40.20. Volume was about 3.2 million, about 25% below the daily average of around 4.5 million shares. The electric utility company had no specific news.

  • [By Joseph Griffin]

    Maple Capital Management Inc. reduced its stake in shares of PPL Co. (NYSE:PPL) by 5.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 143,059 shares of the utilities provider’s stock after selling 8,754 shares during the quarter. Maple Capital Management Inc.’s holdings in PPL were worth $4,047,000 at the end of the most recent reporting period.

  • [By ]

    If this is, indeed, the case, investors have a handful of high quality names at attractive prices to choose from. One that has popped up on my radar is PPL Corporation (NYSE: PPL).

  • [By Joseph Griffin]

    Goelzer Investment Management Inc. boosted its holdings in shares of PPL Co. (NYSE:PPL) by 3.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 120,687 shares of the utilities provider’s stock after acquiring an additional 4,140 shares during the period. Goelzer Investment Management Inc.’s holdings in PPL were worth $3,414,000 at the end of the most recent reporting period.

Top 10 Dividend Stocks To Invest In 2019: United Parcel Service Inc.(UPS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of United Parcel Service (NYSE:UPS) gapped up before the market opened on Tuesday . The stock had previously closed at $113.61, but opened at $115.78. United Parcel Service shares last traded at $115.91, with a volume of 129650 shares changing hands.

  • [By Garrett Baldwin]

    MGM Resorts International (NYSE: MGM) recently purchased Empire City Casino and Yonkers Raceway. The deal will allow the company to capitalize on the sports gambling craze. But there’s another company trading at an incredible discount that presents an amazing opportunity for investors. This is how you could make an easy 100% in the weeks ahead.

    The Top Stock Market Stories for Friday
    Amazon.com Inc. (Nasdaq: AMZN) wiped out the market capitalization of eight different companies on Thursday, cutting $17.5 billion from its capitalization. The e-commerce giant announced plans to recruit entrepreneurs to deliver local packages, hurting the FedEx Corp. (NYSE: FDX) and United Parcel Service Inc. (NYSE: UPS). Amazon also announced it would purchase online pharmacy PillPack, pushing healthcare benefits companies like Walgreens Boots Alliance Inc. (NYSE: WBA) lower.
    Three Stocks to Watch Today: NKE, STZ. WBA
    Shares of Walgreens Boots Alliance Inc. (NYSE: WBA) fell after investment research giant Jefferies downgraded the health benefits firm from a “Buy” to a “Hold.” Jefferies analysts said that the deal between Amazon and PillPack will create more difficult market conditions for retail pharmacy chains. Shares of Nike Inc. (NYSE: NKE) popped 10% this morning after the retailer crushed earnings after the bell on Thursday. The sports apparel giant reported earnings per share (EPS) of $0.69, a figure that beat expectations by $0.05. In addition to beating revenue expectations, the company also announced a $15 billion stock buyback program and said that North American sales increased for the first time in 12 months. Shares of Constellation Brands Inc. (NYSE: STZ) fell more than 4.6% after the beer and liquor manufacturer fell short of profit expectations before the bell. The company reported EPS of $2.20 on top of $2.05 billion in revenue. Wall Street analysts were expecting $2.42 per share on top of $2.04 billion in revenue. The company blamed higher transportation

  • [By ]

    At the beginning of May, after taking a look at the bizarre circumstances surrounding United Parcel Service’s (NYSE: UPS) most recent earnings “beat,” I warned that the stock was set to drop. Despite numerous positive headlines praising the company’s Q1 “win,” the company was suffering from declining profits and operating margins that had been deteriorating for three consecutive quarters.

  • [By Joseph Griffin]

    Gifford Fong Associates acquired a new position in shares of United Parcel Service, Inc. (NYSE:UPS) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 11,800 shares of the transportation company’s stock, valued at approximately $1,235,000.

Top 10 Dividend Stocks To Invest In 2019: Telefonica SA(TEF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Telefonica (BME:TEF) was given a €6.20 ($7.21) target price by analysts at JPMorgan Chase & Co.. The firm currently has a sell rating on the stock.

  • [By Logan Wallace]

    Telefonica (NYSE:TEF) and TELE2 AB/ADR (OTCMKTS:TLTZY) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

  • [By Joseph Griffin]

    Shares of Telefonica SA (BME:TEF) have earned a consensus rating of “Hold” from the sixteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is €8.98 ($10.44).

Top 10 Dividend Stocks To Invest In 2019: Cellcom Israel Ltd.(CEL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Hellenic Telecom Organization (NYSE: CEL) and Cellcom Israel (NYSE:CEL) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations.

  • [By Ethan Ryder]

    Millicom (OTCMKTS: MIICF) and Cellcom Israel (NYSE:CEL) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

  • [By Stephan Byrd]

    Partner Communications (NASDAQ: PTNR) and Cellcom Israel (NYSE:CEL) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Lisa Levin]

    Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

Top 10 Dividend Stocks To Invest In 2019: Lorillard Inc(LO)

Advisors’ Opinion:

  • [By Shane Hupp]

    News articles about Lorillard (NYSE:LO) have been trending extremely positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Lorillard earned a news impact score of 0.81 on Accern’s scale. Accern also gave news coverage about the company an impact score of 44.1727475800447 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Top 10 Dividend Stocks To Invest In 2019: Regal Beloit Corporation(RBC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Regal Beloit (RBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Stephan Byrd]

    Shares of Regal Beloit Corp (NYSE:RBC) have earned an average recommendation of “Buy” from the ten brokerages that are covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $88.63.

Top 10 Dividend Stocks To Invest In 2019: Laboratory Corporation of America Holdings(LH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the headlines that may have impacted Accern Sentiment’s rankings:

    Get Laboratory Corp. of America alerts:

    Stock Traders Buy Large Volume of Laboratory Corp. of America Put Options (LH) (americanbankingnews.com) Credit Suisse Group Lowers Laboratory Corp. of America (LH) to Hold (americanbankingnews.com) Laboratory Corp. of America (LH) Set to Announce Quarterly Earnings on Wednesday (americanbankingnews.com) Can LaunchPad Aid LabCorp's (LH) Covance Arm in Q1 Earnings? (finance.yahoo.com) As Laboratory Corp Of America Holdings (LH) Shares Rose, Shareholder Veritas Investment Management Llp … (djzplanet.com)

    LH has been the subject of several research analyst reports. Craig Hallum restated a “buy” rating and set a $204.00 price target (up from $180.00) on shares of Laboratory Corp. of America in a research note on Wednesday, February 7th. Morgan Stanley upped their target price on Laboratory Corp. of America from $182.00 to $192.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 28th. Zacks Investment Research downgraded Laboratory Corp. of America from a “hold” rating to a “sell” rating in a research report on Wednesday, January 3rd. Mizuho set a $178.00 target price on Laboratory Corp. of America and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Finally, Robert W. Baird set a $183.00 target price on Laboratory Corp. of America and gave the stock a “hold” rating in a research report on Thursday, February 8th. Seven investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $189.19.

  • [By Motley Fool Transcribers]

    Laboratory Corp Of America Holdings  (NYSE:LH)Q4 2018 Earnings Conference CallFeb. 07, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Triangle Securities Wealth Management lifted its stake in Laboratory Corp. of America Holdings (NYSE:LH) by 34.5% in the second quarter, HoldingsChannel.com reports. The fund owned 2,339 shares of the medical research company’s stock after purchasing an additional 600 shares during the period. Triangle Securities Wealth Management’s holdings in Laboratory Corp. of America were worth $420,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Ethan Ryder]

    Laboratory Corp. of America Holdings (NYSE:LH) has been assigned a consensus rating of “Buy” from the eighteen ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $196.64.

Leave a Reply

Your email address will not be published. Required fields are marked *